EU MDR Readiness Reviews — Structured, Independent, Fixed-Scope
B Plus Solutions delivers independent regulatory document reviews for EU MDR compliance.
Structured feedback. Clear risk flags. Submission-ready insight.
Our Services
Regulatory and Strategic Support
EU MDR regulatory strategy, gap assessments, mock audits, and technical documentation review to support manufacturers in preparing compliant and submission-ready documentation.
Clinical and Post-Market Documentation
Clinical Evaluation (CEP, CER, SSCP), PMS and PMCF documentation, literature reviews, and post-market regulatory documentation aligned with EU MDR requirements.
About B+ Solutions
B+ Solutions provides independent regulatory and clinical documentation support for medical device manufacturers navigating EU MDR requirements. With experience on both the manufacturer side and the notified body side, B+ Solutions understands how technical documentation is developed, reviewed, and assessed during conformity assessment. This perspective allows us to deliver structured, practical feedback that strengthens regulatory submissions and helps teams move forward with confidence.
● LIVE
Industry & Compliance Updates
"medical device" - Google News Google News
- Ophthalmic Ultrasound Devices Price in Japan - Market Insights - IndexBoxon 1 May 2026 at 11:17
Ophthalmic Ultrasound Devices Price in Japan - Market Insights IndexBox
- Coiling Assist Stents Price in Northern America - Market Insights - IndexBoxon 1 May 2026 at 11:17
Coiling Assist Stents Price in Northern America - Market Insights IndexBox
- Texas Catheters Price in Brazil - Market Insights - IndexBoxon 1 May 2026 at 11:15
Texas Catheters Price in Brazil - Market Insights IndexBox
- FDA grants breakthrough status to Capitan Orthopedics’ SupraSpacer implant - Medical Device Networkon 1 May 2026 at 11:09
FDA grants breakthrough status to Capitan Orthopedics’ SupraSpacer implant Medical Device Network
- Dexcom reports 15% YoY revenue uptick in Q1 yet maintains prior FY26 outlook - Medical Device Networkon 1 May 2026 at 11:08
Dexcom reports 15% YoY revenue uptick in Q1 yet maintains prior FY26 outlook Medical Device Network